Skip To Main Content
Halkes CJM on Muck Rack

Halkes CJM

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Halkes

Contact Halkes, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT

|
By Eikema DJ, Halkes CJM, Gedde-Dahl T, Wynn RF
| aamds.org
Author(s): Montoro J, Eikema DJ, Tuffnell J, Potter V, Kalwak K, Halkes CJM, Kulagin A, Collin M, Wynn RF, Robinson S, Nicholson E, Sengeloev H, Clay J, Halahleh K, Skorobogatova E, Sanz J, Passweg J, Mielke S, Ryhänen S, Carpenter B, Gedde-Dahl T, Tholouli E, , Fanin R, Lewalle P, Kulasekararaj A, Risitano A, Peffault de Latour R
Open in Who Shared Issue with article?

Quality of life after immune suppressive therapy in aplastic anemia

|
By van Vliet LM, Halkes CJM, Tjon JM
| aamds.org
Acquired aplastic anemia (AA) is a rare form of immune-mediated bone marrow failure, which can result in life-threatening infections or bleeding if left untreated. Treatment consists of either immune suppressive therapy (IST) or allogeneic stem cell transplantation (alloHSCT). While considerable research has been published regarding survival, response rate and toxicity of both treatments, knowledge on the impact on quality of life (QoL) is scarce.
Open in Who Shared Issue with article?
See all 2 articles